Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Rang in aandelen #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2023-05-22
Marktkapitalisatie
$10.03K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel NuGenerex Immuno-Oncology, Inc. (NUGX)

Categorie

Koersgeschiedenis voor NuGenerex Immuno-Oncology, Inc. (NUGX)
Hoogste slotkoers: $0.00 op 2023-05-01

Laagste slotkoers: $1.44 op 2021-03-01
Koersgeschiedenis van NuGenerex Immuno-Oncology, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2023 75.00%
2022 -98.81%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.34%
KR